YOLFTbeta
LENSAR Inc

LENSAR Inc

LNSR · NASDAQ · Healthcare / Medical Devices

5.00USD+0.30 (+6.38%)

Price History

Full chart

Market Stats

Previous Close4.70
Open4.75
Day Range4.68 – 5.08
52-Week Range4.95 – 12.94
Volume46.89K
Market Cap85.02M
P/E (TTM)34.60
Forward P/E0.00
EPS0.20
Dividend Yield0.00%
Beta0.97
50-Day Avg7.11
200-Day Avg8.16

About

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Nicholas T. Curtis
  • Employees150
  • Headquarters2800 Discovery Drive, Orlando, FL, United States, 32826, USA
  • Websitehttps://www.lensar.com

Leadership

  • Mr. Nicholas T. CurtisPresident, CEO & Director · b. 1956
  • Mr. Alan B. ConnaughtonChief Operating Officer · b. 1972
  • Mr. Michael A. RossiInterim CFO & Principal Financial Officer and Secretary · b. 1974
  • Ms. Kendra W. WongPrincipal Accounting Officer · b. 1980

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue24.39M30.53M26.38M34.46M35.36M42.16M53.49M58.44M
Growth (%)-+25.18%-13.58%+30.62%+2.61%+19.25%+26.87%+9.24%
Cost of Revenue14.78M17.30M12.31M16.63M15.40M21.06M27.64M31.31M
Gross Profit9.61M13.23M14.07M17.83M19.95M21.11M25.85M27.12M
Gross Margin39.41%43.33%53.35%51.75%56.44%50.06%48.33%46.41%
Operating Expense18.93M25.94M32.58M37.48M40.13M33.34M36.52M51.70M
Operating Income-9.32M-12.71M-18.50M-19.65M-20.18M-12.23M-10.66M-24.58M
Operating Margin-38.20%-41.65%-70.13%-57.03%-57.06%-29.00%-19.94%-42.06%
EBITDA-4.66M-8.79M-15.36M-16.84M-16.51M-10.87M-3.00M-29.78M
EBITDA Margin-19.12%-28.79%-58.24%-48.86%-46.69%-25.78%-5.62%-50.96%
Net Income-12.59M-14.66M-19.77M-19.60M-19.91M-14.38M-31.40M-34.28M
Net Income Margin-51.64%-48.01%-74.95%-56.88%-56.32%-34.11%-58.71%-58.66%
R&D2.78M7.57M7.55M12.36M11.81M6.14M5.33M5.62M
R&D as % of Total Revenue11.42%24.79%28.63%35.86%33.41%14.56%9.96%9.62%
Interest Expense02.00M1.34M1.19M263.00K---
Interest Expense % of Total Revenue0.00%6.55%5.08%3.45%0.74%---

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets28.89M34.54M79.12M66.47M55.84M69.58M66.30M71.43M
Total Liabilities49.35M65.09M11.91M11.59M13.86M22.41M47.65M97.45M
Total Equity-20.46M-30.55M67.21M54.88M41.98M47.18M18.65M-26.02M
Cash3.34M4.62M40.60M31.64M14.67M20.62M16.26M12.97M
Total Debt41.21M20.53M3.81M3.31M2.80M2.31M2.61M2.73M
Net Debt37.87M15.92M-36.79M-28.32M-11.87M-18.31M-13.65M-10.24M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.89M-12.59M-13.79M-8.97M-14.86M-9.66M-2.27M-14.83M
Investing Cash Flow-3.89M-2.09M-326.00K-354.00K-115.00K-4.16M-2.16M1.28M
Financing Cash Flow6.96M15.95M50.00M361.00K-1.99M19.76M78.00K10.26M
Capital Expenditure3.25M2.09M366.00K354.00K115.00K236.00K156.00K83.00K
Free Cash Flow-5.13M-14.68M-14.16M-9.32M-14.97M-9.89M-2.43M-14.91M
Dividends Paid198.00K31.00K1.86M0----
FCF to OCF272.31%116.59%102.65%103.95%100.77%102.44%106.86%100.56%
Dividend Paid to FCF-3.86%-0.21%-13.15%0.00%----

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Mar 31, 2020Jun 30, 2020Aug 26, 2020Nov 9, 2020Mar 10, 2021May 5, 2021Aug 5, 2021Nov 8, 2021Mar 3, 2022May 9, 2022Aug 8, 2022Nov 9, 2022Mar 16, 2023May 15, 2023Aug 9, 2023Nov 9, 2023Mar 4, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Mar 3, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Dec 31, 2025May 8, 2026Aug 13, 2026Nov 5, 2026
EPS Estimate0.000.000.000.000.000.00-0.64-0.52-0.33-0.59-0.59-0.52-0.58-0.72-0.62-0.25-0.27-0.35-0.34-0.22-0.28-0.29-0.29-0.18-0.15-0.07-0.08-0.100.49-0.27-
EPS Actual-0.33-0.33-5.44-0.42-0.42-13.70-5.44-0.78-0.56-0.47-0.65-0.41-0.67-0.67-0.39-0.24-0.40-0.25-0.28-0.35-0.19-0.12-0.09-0.10-0.06-0.15-0.11-0.11-0.200.10-
Surprise-------750.00%-50.00%-69.70%20.34%-10.17%21.15%-15.52%6.94%37.10%4.00%-48.15%28.57%17.65%-59.09%32.14%58.62%68.97%45.50%60.00%-114.29%-37.50%-7.80%-140.08%137.04%-
Timing------After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap85.02M
Enterprise Value76.66M
Trailing P/E34.60
Forward P/E0.00
Price / Sales1.41
Price / Book5.89
EPS0.20
Book Value1.21
Revenue (TTM)60.26M
Gross Profit (TTM)29.13M
EBITDA-16.33M
Profit Margin57.57%
Operating Margin12.94%
Return on Equity35.73%
Return on Assets-18.66%
Shares Outstanding12.29M
Shares Float8.84M
Beta0.97
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 2 analystsTarget 11.50
  • Hold
    2

Ownership Breakdown

Institutions
45.97%
Insiders
21.52%
Retail / Other
32.51%

Top Institutional Holders

  • Brandes Investment Partners & Co
    1.08M8.75%
  • BlackRock Inc
    628.75K5.12%
  • Vanguard Capital Management, LLC
    390.09K3.18%
  • Geode Capital Management, LLC
    229.74K1.87%
  • Css LLC
    163.45K1.33%
  • Dimensional Fund Advisors, Inc.
    151.61K1.23%
  • Kerrisdale Advisers, LLC
    139.39K1.13%
  • State Street Corp
    135.74K1.10%
  • Millennium Management LLC
    120.68K0.98%
  • DCF Advisers, LLC
    118.22K0.96%
  • Evernest Financial Advisors LLC
    118.10K0.96%
  • The Goldman Sachs Group Inc
    106.89K0.87%
  • Yakira Capital Management, Inc.
    83.29K0.68%
  • UBS Group AG
    83.27K0.68%
  • Man Group PLC
    75.06K0.61%
  • Alpine Partners VI, LLC
    75.00K0.61%

Top Fund Holders

  • Brandes Small Cap Value R6
    532.62K4.34%
  • Vanguard MStar Total Stk Mkt Idx Invest
    275.97K2.25%
  • Stork Fund Dynamic MultiStrategies O EUR
    117.81K0.96%
  • Mediolanum BB Global Sm Cp Eq LA
    88.81K0.72%